2027 ATDC AgendaDownload

2027 Educational Objectives

Upon completion of the program, the participant should be able to:

  1. Evaluate current and emerging evidence-based strategies for the prevention, diagnosis, and management of T1D, T2D, obesity, and related metabolic disorders;
  2. Assess advances in diabetes technologies and their potential integration into clinical practice;
  3. Evaluate established and emerging pharmacologic and biologic therapies for diabetes and obesity;
  4. Categorize contemporary evidence and clinical guidelines for individualized diabetes care;
  5. Summarize strategies to improve clinical outcomes and reduce the burden of diabetes.

2026 Educational Objectives

Upon completion of this program, the participant should be able to:

Participants will engage with cutting-edge advancements transforming diabetes care — from dual glucose and ketone monitoring and next-generation AID systems to breakthroughs in gene editing, cardio-metabolic health, and early intervention in Type 1 diabetes.

The conference empowers attendees to integrate innovation with clinical practice, driving personalized, data-informed, and technology-enabled solutions to optimize outcomes across the spectrum of diabetes management.